Pathology

Pathology/C/40

Inflammatory bowel diseases (ulcerative colitis, Crohn disease)

炎症性腸疾患(潰瘍性大腸炎・クローン病)

タグ
High-yield / ポイント

💡 IBD = group of diseases characterized by an exaggerated and destructive mucosal immune response of the colon and small intestine; includes Crohn’s disease and ulcerative colitis

  • Both are chronic relapsing inflammatory disorders of unknown origin
  • Tissue injury = abnormal local immune response against normal gut flora and self-antigens in genetically susceptible individuals

Pathogenesis:

  • Loss of balance between immune activation (microbes, dietary antigens) and host defenses
  • Involves: genetic susceptibility + failure of immune regulation + microbial factors
  • Both diseases: MHC class 2 alleles + mutated IL-23 receptor gene
  • Crohn’s: NOD2 mutation (host response to bacteria)
  • Primary damaging agent: CD4+ T-cells; TNF plays an important role in Crohn’s
  • Sites (ileum and colon) are rich in bacteria that provide the antigenic trigger
  • Outcome: impaired mucosal barrier + loss of surface epithelium → intermittent bloody diarrhea

A) Crohn’s Disease (CD)

  • May affect any portion of the GI-tract (esophagus to anus); usually the terminal ileum
  • Systemic inflammatory disease; peak incidence 20–30 years of age; females slightly more affected

Morphology

  • Skip lesions: sharp demarcation of diseased segments from adjacent normal bowel
  • Serpentine fissures: deep ulcers in the long axis separated by nodular mucosal thickenings
  • Fibrosisstricture of involved segments (esp. terminal ileum)
  • Extension of fissures → fistula formation (to bowel loops, bladder, vagina, perianal skin) + peritoneal abscesses

Clinical

  • Recurrent episodes of diarrhea, crampy abdominal pain, fever; slow onset (sometimes abrupt)
  • Melena (black tarlike stool = digested blood) in ~50% of cases
  • Symptom-free periods followed by relapses

Complications

  • Fistulas, abdominal abscesses, intestinal stricture/obstruction
  • Extraintestinal (immune origin): uveitis, sacroiliitis, migratory polyarthritis, erythema nodosum, bile duct disorders, obstructive uropathy

B) Ulcerative Colitis (UC)

  • Ulceroinflammatory disease limited to the colon (mucosa + submucosa); starts in the rectum and extends proximally in a continuous fashion; may involve the whole colon
  • Peak 20–25 years of age; same extraintestinal associations as CD

Key differences from Crohn’s Disease

Feature Crohn’s Disease Ulcerative Colitis
Location Any GI tract; terminal ileum Colon only
Skip lesions Yes No
Granulomas Yes No
Depth of ulcers Transmural Mucosa + submucosa
Fibrosis/stricture Yes Little
Mural thickening Yes No
Carcinoma risk Lower Higher

Morphology

  • Macro: broad-based ulcers; pseudopolyps (narrow strands of edematous hyperemic mucosa bulging upward between ulcers)
  • Micro: PMNL infiltration → crypt abscess → mucosal destruction; crypt atrophy → dysplasia

Clinical

  • Bloody mucoid diarrhea + cramps, tenesmus, lower abdominal pain; chronic relapsing
  • Complications: mucosal atrophy, bleeding/anemia, epithelial dysplasia → carcinoma

💡 High-yield: CD = skip lesions + serpentine fissures + transmural + fistulas + terminal ileum; NOD2. UC = continuous from rectum + pseudopolyps + crypt abscess + higher carcinoma risk; no granulomas. Both: CD4+ T-cells; TNF (CD); extraintestinal = uveitis, sacroiliitis, erythema nodosum.